Cargando…

Treatment of Hyperparathyroidism (SHPT)

Detalles Bibliográficos
Autores principales:	Hernandes, Fabiana Rodrigues, Goldenstein, Patrícia, Custódio, Melani Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2021
Materias:	Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823921/ https://www.ncbi.nlm.nih.gov/pubmed/34910799 http://dx.doi.org/10.1590/2175-8239-JBN-2021-S107

Ejemplares similares

Mineral and bone disorder after kidney transplantation (KTx)
por: Neves, Carolina Lara, et al.
Publicado: (2021)

Aluminum Intoxication in Chronic Kidney Disease
por: de Oliveira, Rodrigo Bueno, et al.
Publicado: (2021)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

The Significance of Ultrasound in Determining Whether SHPT Patients Are Sensitive to Calcitriol Treatment
por: Liang, Xing-xin, et al.
Publicado: (2016)

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study
por: Ketteler, Markus, et al.
Publicado: (2012)

Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study
por: Ketteler, Markus, et al.
Publicado: (2012)

Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients
por: Jäger, Mark D., et al.
Publicado: (2017)

Parathyroidectomy Improves Survival In Patients with Severe Hyperparathyroidism: A Comparative Study
por: Goldenstein, Patricia Taschner, et al.
Publicado: (2013)

The Value of the Model and Quantitative Parameters of Contrast-Enhanced Ultrasound in Judging the Severity of SHPT
por: Liang, Xing-xin, et al.
Publicado: (2016)

Study on the correlation between mineral bone metabolism and CRP in patients with SHPT during perioperative period
por: Yan, Lei, et al.
Publicado: (2023)

Part 4: Myelodysplastic syndromes—Treatment of low-risk patients with the 5q deletion
por: Magalhães, Silvia Maria Meira, et al.
Publicado: (2018)

Part 5: Myelodysplastic syndromes—Treatment of high-risk disease
por: Magalhães, Silvia Maria Meira, et al.
Publicado: (2018)

Control of hyperphosphatemia and maintenance of calcemia in CKD
por: Carvalho, Aluizio Barbosa, et al.
Publicado: (2021)

Diagnosis of vascular calcification related to mineral and bone metabolism disorders in chronic kidney disease
por: Bonato, Fabiana Oliveira Bastos, et al.
Publicado: (2021)

Part 3: Myelodysplastic syndromes—Treatment of low-risk patients without the 5q deletion
por: Velloso, Elvira Deolinda Rodrigues Pereira, et al.
Publicado: (2018)

Use of absorbable versus nonabsorbable anchors in the treatment of glenohumeral instability
por: Anzai, Adriano, et al.
Publicado: (2022)

Treatment of multiple sclerosis
por: Pandit, Lekha, et al.
Publicado: (2011)

Sugammadex in awakening from general anesthesia: systematic review and meta-analysis
por: Anzai, Adriano, et al.
Publicado: (2022)

Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus
por: Young, Susan, et al.
Publicado: (2020)

Treatment in late Parkinson's disease
Publicado: (2011)

Bell's palsy: Treatment guidelines
por: Murthy, J. M. K., et al.
Publicado: (2011)

Severe influenza treatment guideline
por: Choi, Won Suk, et al.
Publicado: (2014)

Treatment of Osteoporosis in Chronic Kidney Disease
por: Barreto, Fellype Carvalho, et al.
Publicado: (2021)

Acute disseminated encephalomyelitis: Treatment guidelines
por: Alexander, M., et al.
Publicado: (2011)

Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)

German guidelines on the diagnosis and treatment of neurosyphilis
por: Klein, Matthias, et al.
Publicado: (2020)

Chinese expert consensus on the treatment of MMD
por: Bao, Xiang-Yang, et al.
Publicado: (2023)

2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension
Publicado: (2019)

Guidelines for Prevention and Treatment of Chronic Hepatitis B
por: Wang, Guiqiang, et al.
Publicado: (2021)

Initiation of treatment in early PD (evidences based)
Publicado: (2011)

Korean treatment recommendations for patients with axial spondyloarthritis
por: Seo, Mi Ryoung, et al.
Publicado: (2023)

Diagnosis and treatment of calciphylaxis in patients with chronic kidney disease
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

2018 Chinese Guidelines for the Diagnosis and Treatment of Rheumatoid Arthritis
por: Tian, Xinping, et al.
Publicado: (2021)

Saudi guidelines for testing and treatment of latent tuberculosis infection
por: Al Jahdali, Hamdan H., et al.
Publicado: (2010)

APASL consensus statements and recommendation on treatment of hepatitis C
por: Omata, Masao, et al.
Publicado: (2016)

Chinese expert consensus on clinical prevention and treatment of scar(+)
por: Lv, Kaiyang, et al.
Publicado: (2018)

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
por: Park, So Young, et al.
Publicado: (2018)

Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)
por: Zhang, Zhiyi, et al.
Publicado: (2020)

Japan Stroke Society Guideline 2021 for the Treatment of Stroke
por: Miyamoto, Susumu, et al.
Publicado: (2022)

Clinical guideline for the diagnosis and treatment of cutaneous warts (2022)
por: Zhu, Peiyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_star03lu6u1shr2hkq9gmn059q